What is NDC 13517-100?

13517-100 is the product NDC for Diazoxide, Diazoxide 50 mg/mL suspension, listed with the FDA by e5 Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

e5 Pharma, LLC, NDC labeler code 13517. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Diazoxide?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Diazoxide NDC 13517-100 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)13517-100Labeler and product segments. Claims need a package NDC.

Product NDC at billing width13517-0100Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
13517-100-30	13517010030	1 BOTTLE, DROPPER in 1 CARTON (13517-100-30) / 30 mL in 1 BOTTLE, DROPPERMarketed from Dec 11, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Diazoxide
Generic name (nonproprietary): diazoxide
Active ingredients: Diazoxide — 50 mg/mL
Dosage form: Suspension
Route: Oral
Labeler: e5 Pharma, LLCNDC labeler code 13517
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211050
Marketing start: Dec 11, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 13517-100_11c83c92-145b-486a-90f3-d759c358d091SPL ID 11c83c92-145b-486a-90f3-d759c358d091SPL set ID c0237320-2d3f-4907-a4d3-08f138aa4ca8RxCUI 197593UNII O5CB12L4FNUPC 0313517100300

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N413517010030 followed by a unit qualifier and the quantity

Package 13517-0100-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 31, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Diazoxide Oral Suspension is indicated for the management of hypoglycemia due to hyperinsulinism associated with the following conditions: Adults: Inoperable islet cell adenoma or carcinoma, or extrapancreatic malignancy. Infants and Children: Leucine sensitivity, islet cell hyperplasia, nesidioblastosis, extrapancreatic malignancy, islet cell adenoma, or adenomatosis. Diazoxide Oral Suspension may be used preoperatively as a temporary measure, and postoperatively, if hypoglycemia persists. Diazoxide should be used only after a diagnosis of hypoglycemia due to one of the above conditions has been definitely established. When other specific medical therapy or surgical ma…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 13517-100

What is NDC 13517-100?: 13517-100 is the product NDC for Diazoxide, Diazoxide 50 mg/mL suspension, listed with the FDA by e5 Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Diazoxide.
What is the active ingredient?: Diazoxide.
Who is the labeler?: e5 Pharma, LLC, NDC labeler code 13517. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Diazoxide?: 1 other product NDC are listed under this name. See all Diazoxide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Diazoxide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Diazoxide	Diazoxide 50 mg/mL	SuspensionOral	Par Health USA, LLC	0254-1010	00254-1010-19